Pharmafile Logo

Medscape Oncology Launches Inaugural Medscape Fellows Program at ASCO 2024

- PMLiVE

Medscape Oncology is excited to announce the launch of the first-ever Medscape Fellows Program at the 2024 ASCO meeting in Chicago, Illinois. This groundbreaking program aims to nurture young oncology talent and advance outcomes through education.

“Today’s fellows represent the future of oncology. Our Medscape Oncology Fellows are poised to become leaders in cancer care, and we wanted to bring them together at oncology’s biggest event in the United States to show them the impact they can make. We’re looking forward to a weekend full of events and programs for them,” said Natasha McGrath, Executive Director, Medscape Education.

The Medscape Fellows Program will kick off with a welcome reception and feature a series of events throughout the weekend designed to inspire, educate, and connect fellows with leading experts in the field. By engaging in workshops, networking opportunities, symposia, and focus group sessions, fellows will gain valuable insights and skills to advance their careers and improve patient outcomes.

Medscape will also use insights from this program to help build new tools and programs designed to engage and elevate both fellows and young faculty. By placing education at the forefront, Medscape aims to advance clinical practice and improve patient outcomes.

For more information on the Medscape Fellows Program, please contact Natasha McGrath at NMcGrath@Medscape.net.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?

Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...

DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE

During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...

ESMO’s New Focus on Cancer Prevention

During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...

ESMO Patient Centricity – Highlights from Steve Clark

During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK),...

ESMO Patient Centricity Highlights from Dr. Whyte

During #ESMO22 we brought together a panel of world-renowned experts, including WebMD CMO John Whyte, Professor Nadia Harbeck, MD, PhD, Lesley Fallowfield DBE, and Steve Clark, patient advocate and campaigns ambassador, Cancer Research UK (CRUK), volunteer...

Closing The Gaps in Patient-Centricity in Cancer Care

Highlights from the Medscape Education full panel discussion during this year's #ESMO22.

Full Panel Discussion: Closing The Gaps In Patient-Centricity

On 11th September, the Medscape team came together at the Eiffel Tower for an exciting event attended by expert faculty, patient advocates and more than a hundred supporters of our...

Medscape Education: Key Takeaways from Tapas and Trends

This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data...

Medscape Education #ESC Tapas and Trends Full Panel Discussion

This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data...

A Look at What’s Next After ESC

This year at ESC, Medscape Education Global gathered with conference attendees and leading KOLs for an education event at the Gaudi House in Barcelona where they examined the new data...